Parkinson Disease Market Report: Trends, Forecast and Competitive Analysis to 2030

Parkinson Disease Trends and Forecast

The future of the global parkinson disease market looks promising with opportunities in the carbidopa-levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors, and anticholinergics markets. The global parkinson disease market is expected to reach an estimated $8.8 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are rising aging population, advances in diagnostic technologies, and increasing healthcare expenditure in emerging economies.

A more than 150-page report is developed to help in your business decisions.

Parkinson Disease by Segment

The study includes a forecast for the global parkinson disease by drug class, distribution channel, and region.

Parkinson Disease Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

• Carbidopa-Levodopa
• Dopamine Agonists
• Mao-B Inhibitors
• Comt Inhibitors
• Anticholinergics
• Others

Parkinson Disease Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Parkinson Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Parkinson Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies parkinson disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the parkinson disease companies profiled in this report include-

• Cerevel Therapeutics
• Novartis
• Teva Pharmaceutical Industries
• Merck & Co.
• GlaxoSmithKline
• AbbVie
• H. Lundbeck

Parkinson Disease Market Insights

Lucintel forecasts that retail pharmacy will remain the largest segment over the forecast period due to ease of availbility.

North America will remain the largest region over the forecast period due to large number of important participants, high disposable income, high costs for healthcare, and an established healthcare system in this area.

Features of the Global Parkinson Disease Market

Market Size Estimates: Parkinson disease market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Parkinson disease market size by drug class, distribution channel, and region in terms of value ($B).

Regional Analysis: Parkinson disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drug class, distribution channel, and regions for the parkinson disease market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the parkinson disease market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the parkinson disease market size?

Answer: The global parkinson disease market is expected to reach an estimated $8.8 billion by 2030.

Q2. What is the growth forecast for parkinson disease market?

Answer: The global parkinson disease market is expected to grow with a CAGR of 6.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the parkinson disease market?

Answer: The major drivers for this market are rising aging population, advances in diagnostic technologies, and increasing healthcare expenditure in emerging economies.

Q4. What are the major segments for parkinson disease market?

Answer: The future of the global parkinson disease market looks promising with opportunities in the carbidopa-levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors, and anticholinergics markets.

Q5. Who are the key parkinson disease market companies?

Answer: Some of the key parkinson disease companies are as follows:

• Cerevel Therapeutics
• Novartis
• Teva Pharmaceutical Industries
• Merck & Co.
• GlaxoSmithKline
• AbbVie
• H. Lundbeck

Q6. Which parkinson disease market segment will be the largest in future?

Answer: Lucintel forecasts that retail pharmacy will remain the largest segment over the forecast period due to ease of availbility.

Q7. In parkinson disease market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to large number of important participants, high disposable income, high costs for healthcare, and an established healthcare system in this area.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the parkinson disease market by drug class (carbidopa-levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors, anticholinergics, and others), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?